Memory and thinking skills may decline faster in Parkinson's patients who have a high-risk gene variant.
Experts say a landmark study has found certain gene mutations can be targeted with newer drug therapies.
The research is preliminary and plenty of work remains, but an animal study shows promise.
Discovery could give hope to patients who rarely live beyond their 30s.
